ANALYSIS OF EFFECTIVENESS, SAFETY AND COST OF DIFFERENT DOSES OF RITUXIMAB IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Mena-Vazquez, N. [1 ]
Manrique-Arija, S. [1 ]
Ordonez-Canizares, M. C. [1 ]
Domic, C. [1 ]
Urena-Garnica, I. [1 ]
Barco, C. M. Romero [1 ]
Jimenez-Nunez, F. G. [1 ]
Rojas-Gimenez, M. [1 ]
Fuego, C. [1 ]
Cano-Garcia, L. [1 ]
Irigoyen-Oyarzabal, M. V. [1 ]
Coret, V. [1 ]
Belmonte-Lopez, A. [1 ]
Fernandez-Nebro, A. [1 ]
机构：
[1] Univ Malaga, Hosp Reg Malaga, Inst Invest Biomed Malaga IBIMA, UGC Reumatol, Malaga, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0177
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [31] Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis
    van Vollenhoven, R. F.
    Emery, P.
    Bingham, C.
    Keystone, E.
    Greenwalds, M.
    Moreland, L. W.
    Kim, D.
    Cooper, S.
    Wagner, B.
    Ward, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 332 - 332
  • [32] COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS. RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
    Gao, X.
    Hwang, S.
    Carpiuc, K. T.
    Stephens, J. M.
    Sato, R.
    Singh, A.
    Rivera, R.
    Garcia, E.
    Bierschwale, H.
    VALUE IN HEALTH, 2009, 12 (03) : A67 - A67
  • [33] COST-EFFECTIVENESS ANALYSIS OF TWO RITUXIMAB BASED THERAPEUTIC REGIMENS FOR LONGSTANDING RHEUMATOID ARTHRITIS
    Quartuccio, L.
    Di Bidino, R.
    Ruggeri, M.
    Biasi, D.
    Adami, S.
    Schiavon, F.
    Punzi, L.
    Cicchetti, A.
    De Vita, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 563 - 563
  • [34] Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan
    Adil, Muhammad Hammas
    Ghufran, Ayisha
    Farooqi, Abid Z.
    RAWAL MEDICAL JOURNAL, 2016, 41 (02): : 160 - 165
  • [35] A cost effectiveness analysis of cyclosporine in rheumatoid arthritis
    Anis, AH
    Tugwell, PX
    Wells, GA
    Stewart, DG
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (04) : 609 - 616
  • [36] EFFECT OF DIFFERENT DOSES OF RITUXIMAB ON THE PROGRESSION OF BONE DESTRUCTION IN RHEUMATOID ARTHRITIS (RA)
    Pivanova, A. V.
    Lukina, G. V.
    Sigidin, Y. A.
    Smirnov, A. V.
    Kuzikyants, K. H.
    Kuznetsova, A. Y.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A39 - A40
  • [37] Long-term Effectiveness of Ultra-Low Doses of Rituximab in Rheumatoid Arthritis
    den Broeder, Nathan
    Verhoef, Lise
    De Man, Yael
    Kok, Marc
    Thurlings, Rogier
    van der Weele, Wilfred
    van den Bemt, Bart
    van den Hoogen, Frank
    van der Maas, Aatke
    den Broeder, Alfons
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3031 - 3034
  • [38] LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS
    Den Broeder, N.
    Verhoef, L. M.
    De Man, Y. A.
    Kok, M. R.
    Thurlings, R. M.
    Van der Weele, W.
    Van den Bemt, B.
    Van den Hoogen, F.
    Van der Maas, A.
    Den Broeder, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 597 - 598
  • [39] Cost-benefit of rituximab for rheumatoid arthritis patients in Argentina
    Sole, J. P.
    Ortega, G. P.
    Kielhorn, A.
    VALUE IN HEALTH, 2007, 10 (06) : A243 - A244
  • [40] TREATMENT WITH RITUXIMAB TO DEMAND IN RHEUMATOID ARTHRITIS. EFFECTIVENESS ANALYSIS
    Julia, U.
    Fobelo, M. J.
    Guzman, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : A66 - A66
12345